NN

Nilufar Nezam

Active Director Designated Partner DIN 11025359
DIN 11025359 First appointment Mar 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2025
Shareholding value Locked Premium profile

About Nilufar Nezam

Nilufar Nezam has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Mozelo Pharma Llp. Engaged in General Business. Contributes to corporate operations.

DIN 11025359
Primary Designation Designated Partner
First Appointment 28 Mar 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Designated Partner 28 Mar 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mozelo Pharma Llp
Premium access

Shareholding and investment profile for Nilufar Nezam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilufar Nezam

Nilufar Nezam has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Mozelo Pharma Llp. Engaged in General Business. Contributes to corporate operations.

Nilufar Nezam is associated with 1 company as Designated Partner.

Nilufar Nezam has expertise in General Business.

Nilufar Nezam has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available